Neoadjuvant Treatment With Nab-paclitaxel for Patients With Stage II and III Luminal Breast Cancer
NCT01565499
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Nab-paclitaxel
Sponsor
Spanish Breast Cancer Research Group
Collaborators
[object Object]